Stay updated on Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial

Sign up to get notified when there's something new on the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of Medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:32:15.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 02 26 to 05 29, indicating an update or revision related to the medical and healthcare publication or documentation concerning the study 'Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence (CAPTiRALL).'
    Difference
    0.6%
    Check dated 2024-05-30T09:25:55.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of relevant medical or healthcare-related publications or documentation. This change may reflect new information or additional studies being added to the database.
    Difference
    0.3%
    Check dated 2024-05-22T21:26:11.000Z thumbnail image
  8. Check
    39 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:26:56.000Z thumbnail image

Stay in the know with updates to Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page.